Bramble & Co: acquisition or staged entry into continental Europe

Option A: acquisition

• Leverage and covenant risk. Moving from 1.1x to 3.2x leaves roughly 0.3x of headroom against a 3.5x ceiling. If combined EBITDA falls by about 9%, the covenant is breached, before any integration cost. That is a thin margin for a cyclical target.
• Concentration stacking. The target derives 60% of revenue from two wholesalers, and Bramble already has 22% of UK revenue in one customer. Post-deal, the group becomes structurally dependent on a small number of counterparties whose contracts the board does not control.
• Integration and currency risk. Systems, culture and language integration is a known destroyer of value. Euro-denominated earnings add translation exposure on top of the existing unhedged 18% input cost exposure.
• Regulatory timing. Reformulating two SKUs for the labelling change will absorb management capacity that the acquisition would also need.
• Why it appeals: immediate manufacturing footprint, distribution and scale; it is a real option on EU growth that organic entry cannot buy quickly.

Option B: organic launch

• Lower capital at risk. £8m against £60m, with staged funding and an option to stop at each gate. Covenant headroom is preserved.
• Execution risk. Bramble has no proven German e-commerce or retail capability. Break-even in year three is an assumption, not a plan, and retail partners will demand promotional spend.
• Slower scale and weaker control of brand in a new market. It does not solve the growth problem if competitors consolidate first.

Recommendation Proceed with Option B, structured as a gated real option: release £2.5m for a 6-month market test, with gate criteria on customer acquisition cost, repeat purchase rate and gross margin. In parallel, keep Option A alive only on revised terms: part-equity funding to keep leverage below 2.5x, an earn-out tied to retaining the two wholesalers, and a condition that no completion occurs until the labelling reformulation is complete. As presented, Option A is inconsistent with the stated appetite and with the CFO's legitimate covenant concern.

Purpose Stress testing here is not about producing a single forecast. It is about discovering the conditions under which the chosen strategy destroys value or breaches a constraint, and pre-agreeing what the board will do when those conditions appear.

Scenario design Build three coherent scenarios over 36 months: base, downside and severe. Vary the drivers that actually matter:

• German demand and price elasticity: volume 20% below plan in the downside, 40% below in the severe case.
• EUR/GBP movement of plus or minus 10-15%, applied to both input costs and any euro revenue.
• Interest rates plus 200 basis points on the debt drawn.
• Loss of the UK grocery customer (22% of revenue) occurring in the same year as the EU launch.
• Labelling reformulation cost and delay: assume a 6-month slip and a 30% cost overrun.
• E-commerce customer acquisition cost 50% above plan.

Reverse stress test Ask what combination would breach the 3.5x covenant or exhaust liquidity. That gives the board the distance-to-default in plain terms, and it converts an abstract appetite statement into a number.

Trigger points and KRIs

• Net debt/EBITDA above 2.5x for two consecutive quarters: freeze discretionary spend and suspend any acquisition integration costs.
• German contribution margin negative after month 12: stop phase two funding and review the channel mix.
• Customer acquisition cost more than 1.5x plan for two quarters: renegotiate retail partner terms or exit the channel.
• EUR/GBP outside an agreed band: activate the hedging policy, which must exist before launch.
• UK top-customer volume down more than 5%: convene the board and re-run the severe scenario.

Governance Each KRI needs an owner, a data source, a reporting frequency and a pre-agreed action. Monitoring without pre-committed action becomes commentary. Review at the risk committee quarterly and require a formal re-approval gate at months 6 and 12.

Diagnose the inconsistency A blanket 'low appetite for risk' is not an appetite statement; it is an aspiration that gives management no guidance. Every growth option requires the board to accept some risk, so a statement that appears to reject all risk forces managers either to ignore it or to present decisions as risk-free when they are not. Both outcomes are worse than a calibrated statement.

Build a three-layer statement

• Risk capacity: the hard limits the board cannot breach. Here: covenant headroom of at least 0.5x, liquidity of at least £10m, and no single customer above 25% of revenue.
• Appetite by category: the board may be risk-averse on regulatory, safety and reputational risk, and deliberately risk-seeking on strategic growth risk, provided the capital at risk is bounded and reversible.
• Tolerances: quantified limits within each category, with green, amber and red thresholds and named owners.

For this decision, a workable appetite statement would be: the board will accept strategic risk where the maximum capital at risk is £10m, the probability of covenant breach in any year is below 5%, and there is a credible exit within 24 months. That immediately rules Option A in its current form in or out on evidence rather than on slogan.

Govern the decision

• Require a board paper that presents both options with risk-adjusted returns, sensitivity analysis, the reverse stress test, and an explicit statement of what the board is choosing to accept.
• Record dissent and the reasoning, particularly the CFO's covenant concern, so that the decision is defensible after the event.
• Separate the decision to explore from the decision to commit: approve the gated £2.5m test, not the full programme.
• Schedule a post-implementation review at month 12 against the gate criteria, with a named sponsor.
• Revisit the appetite statement annually and after any material event, because an appetite that is never recalibrated becomes decorative.

Judgement The board's real choice is not risk versus no risk. It is between a large, irreversible, concentrated bet and a smaller, staged, reversible one. The appetite statement should be written so that it makes that distinction visible.